Duration of high-dose interferon alpha-2b regimen for resected high-risk melanoma

J Clin Oncol. 2009 Sep 1;27(25):e82-3; author reply e84. doi: 10.1200/JCO.2009.23.0334. Epub 2009 Jul 27.
No abstract available

Publication types

  • Letter
  • Research Support, N.I.H., Extramural
  • Comment

MeSH terms

  • Antineoplastic Agents / administration & dosage*
  • Chemotherapy, Adjuvant
  • Disease-Free Survival
  • Drug Administration Schedule
  • Humans
  • Interferon alpha-2
  • Interferon-alpha / administration & dosage*
  • Melanoma / drug therapy*
  • Melanoma / mortality
  • Melanoma / pathology
  • Melanoma / surgery
  • Neoplasm Staging
  • Recombinant Proteins
  • Research Design
  • Skin Neoplasms / drug therapy*
  • Skin Neoplasms / mortality
  • Skin Neoplasms / pathology
  • Skin Neoplasms / surgery
  • Treatment Outcome

Substances

  • Antineoplastic Agents
  • Interferon alpha-2
  • Interferon-alpha
  • Recombinant Proteins